BeStock  
Stocks › Biotechnology › LKFT

Lakefront Biotherapeutics LKFT

US equityMarket cap rank #2629Biotechnology
$33.31 −$0.08 (-0.24%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $33.31 0.00%
Open$33.61
Prev close$33.39
Day range$33.25 – $33.85
Volume162.5K
Market cap$2.18B
P/E (TTM)2.5
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings2.6x
CheapRich

Above its usual level · 61st percentile, 5-year average 15.3x

#119 of 2994 stocks by PE (1 = cheapest)

Price / book0.6x
CheapRich

Below its usual level · 27th percentile, 5-year average 0.9x

#809 of 5335 stocks by PB (1 = cheapest)

Price / sales2.2x
CheapRich

Near the bottom of its 5-year range · 16th percentile, 5-year average 4.8x

#2677 of 5159 stocks by PS (1 = cheapest)

P/E over five years

-90x37x164x291xOct '21Jun '23Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$36.38
Price vs. fair value-8.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 0.63 – 0.91 27% (cheaper than usual) #809 of 5335 (1 = cheapest)
PE 2.55 -21.92 15.34 61% (pricier than usual) #119 of 2994 (1 = cheapest)
PS 2.19 62.69 4.83 16% (cheaper than usual) #2677 of 5159 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on LKFT.

Sign in to join the discussion.

Scroll to Top